Chemical process

Details for Australian Patent Application No. 2006296367 (hide)

Owner AstraZeneca AB

Inventors Squire, Christopher John; Patel, Zakariya; Sependa, George Joseph; Hogan, Philip John; Blixt, Jorgen; Wright, Nicholas Cartwright Alexander; Pittam, John David; Montgomery, Francis Joseph; Golden, Michael David; Martin, David Michael Glanville

Agent Davies Collison Cave

Pub. Number AU-B-2006296367

PCT Pub. Number WO2007/036713

Priority 0519879.1 30.09.05 GB

Filing date 27 September 2006

Wipo publication date 5 April 2007

Acceptance publication date 11 August 2011

International Classifications

C07D 211/16 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 239/94 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/036713 Priority application(s): WO2007/036713

11 August 2011 Application Accepted

  Published as AU-B-2006296367

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006296369-Compounds which have activity at M1 receptor and their uses in medicine

2006296353-Non-pressurised pre-treatment, enzymatic hydrolysis and fermentation of waste fractions